Orifarm

The Orifarm team is excited to be at INFARMA Madrid – and we’re already off to an inspiring start engaging with many fantastic partners, suppliers, and industry colleagues 🌟   We’re really looking forward to a productive few days filled with great conversations, insights, and connections.   If you’re at INFARMA and would like to connect, feel free to reach out. We’d be delighted to set up a time to talk.   Looking forward to connecting with many of you during INFARMA this week.

Orifarm joins the Business Council at Lodz University of Technology🤝   We are pleased to share that Orifarm has joined the Business Council of the Faculty of Process and Environmental Engineering (WIPOŚ) at Lodz University of Technology, represented by Łukasz Dawidowicz, Piotr Urbański and Maciej Nawrocki.   With a complex and highly regulated pharmaceutical production setup, attracting the right engineering talent is crucial to ensuring quality, innovation and growth. Close cooperation with universities helps us connect with ambitious students, share real‑world industry insights and highlight the rewarding career opportunities we offer across our manufacturing and technical functions.   Through this partnership, Orifarm will be able to influence the development of future engineers while benefiting from the strong research and technological capabilities of WIPOŚ PŁ. Together, we aim to build a pipeline of skilled professionals ready to take on meaningful challenges in the pharma industry.   We look forward to shaping the next generation of engineering talent alongside a forward‑thinking academic partner.

Our commitment to environmental, social, and governance responsibility isn’t something we add on top. It’s built into how we operate, decide, and create impact.     Our 2025 ESG Report shows how we put that commitment into action:     🌍 reducing our environmental footprint  💚 building a diverse, safe, and inclusive workplace for all colleagues  🔍 strengthening responsible business practices across our value chain    The report reflects progress – and a promise. You can find the full report here: https://lnkd.in/exgp_2QK  

Curious to know more about Orifarm’s strongest financial year to date? Explore the highlights below! 👇 These numbers aren't just figures in a report; they allow us to make high-quality medicines more accessible at better prices across Europe. This year, we’re building on our momentum bringing even more products to patients.  

Today colleagues at our headquarters in Odense, Denmark, and our manufacturing site in Hobro, Denmark, took part in a Danish charity tradition called Football Shirt Friday to raise awareness and funds for children affected by cancer. ⚽💛 More than 250 colleagues turned up in their favorite jerseys to support Børnecancerfonden, the Danish Children’s Cancer Foundation. While the purpose is what truly matters, it was also a wonderful moment of connection and team spirit.

𝗪𝗲 𝗮𝗿𝗲 𝗽𝗿𝗼𝘂𝗱 𝘁𝗼 𝘀𝗵𝗮𝗿𝗲 𝗢𝗿𝗶𝗳𝗮𝗿𝗺’𝘀 𝘀𝘁𝗿𝗼𝗻𝗴𝗲𝘀𝘁 𝗳𝗶𝗻𝗮𝗻𝗰𝗶𝗮𝗹 𝗽𝗲𝗿𝗳𝗼𝗿𝗺𝗮𝗻𝗰𝗲 𝘁𝗼 𝗱𝗮𝘁𝗲. In 2025, we delivered record revenue of 2 billion euros, EBITDA above 150 million euros, and a four-fold increase in free cash flow.  With strong commercial momentum and increasing profitability, this breakthrough year puts Orifarm on a stronger path for future growth. Our performance strengthens our ability to deliver on our purpose: improving affordability and accessibility to create healthier days for more people across Europe. Thank you to our 2,300 dedicated employees. You’re the ones who make this possible! See press release here: https://lnkd.in/eP6b-EV9 👉 Watch our CEO, Mads Fink Eriksen, share our annual results in the video below. 

Today, we celebrate Orifarm’s founder Hans Bøgh-Sørensen turning 70. For more than three decades, Hans’ strong entrepreneurial spirit and willingness to challenge the established pharmaceutical industry have shaped Orifarm’s mission: ensuring that patients across Europe have better access to high‑quality medicines at more affordable prices. Since founding Orifarm in 1994 with his wife, Birgitte Bøgh-Sørensen, Hans has driven the company’s development into one of Europe’s leading suppliers of parallel‑imported medicines, generics, and over-the-counter products. Today, 2,300 colleagues across 16 countries work to advance this commitment to accessibility and affordability for millions of patients. Please join us in wishing Hans a warm and heartfelt happy 70th birthday!🎂

We’re excited to share that Orifarm will attend INFARMA Madrid 2026 – and we can’t wait to see you there! Our team is truly looking forward to reconnecting with our many valued partners and meeting new ones. Such events are a fantastic opportunity to strengthen existing collaborations, explore new opportunities, and continue building strong, trust‑based relationships across the industry. 🤝 Let’s connect! If you're attending INFARMA and would like to meet, reach out to the Orifarm team – we’d be happy to schedule time with you. Looking forward to productive conversations and new possibilities. See you in Madrid!

🤝🌍 𝐒𝐭𝐫𝐨𝐧𝐠 𝐛𝐨𝐧𝐝𝐬 𝐛𝐞𝐭𝐰𝐞𝐞𝐧 𝐎𝐫𝐢𝐟𝐚𝐫𝐦 𝐜𝐨𝐮𝐧𝐭𝐫𝐢𝐞𝐬 At Orifarm, strong collaboration across our countries is at the heart of how we excel and grow. Last week, our Chief Commercial Officer Thomas Brandhof sat down in our studio to record a video greeting for our colleagues in Orifarm Germany – 𝘪𝘯 𝘎𝘦𝘳𝘮𝘢𝘯. It’s a very small gesture but with a bigger purpose: all teams across Europe are closely connected, committed, and working side by side toward the same goals. As Thomas Brandhof puts it: “Building strong connections across our countries is essential. When we stay in close contact and truly understand each other – across languages, cultures, and borders – we function as an interconnected network and collaborate in the best possible way.” Our German team continues to deliver impressive results. This success is a great example of what we can accomplish when we collaborate across borders and support each other as one Orifarm. Let’s keep building these strong relationships and celebrating the great work happening in – and across – all Orifarm countries.